| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 12, 2005
From the Departments of Epidemiology & Biostatistics (M.J.B., A.H., J.C.M.W., M.M.B.B.) and Neurology (M.J.B., P.J.K.), Erasmus Medical Center, Rotterdam, The Netherlands. * To whom correspondence should be addressed. E-mail: m.breteler{at}erasmusmc.nl.
Background and Purpose--The role of uric acid as a risk factor for myocardial infarction is controversial, and little is known about its role as a risk factor for stroke. Recent evidence suggests that uric acid may be an important causal agent in cardiovascular disease, for example, by inducing renal disease and hence hypertension. We investigated the association between serum uric acid and coronary heart disease and stroke in a large prospective population-based study. Methods--The study was based on 4385 participants of the Rotterdam Study who, at baseline (1990 to 1993), were Results--Average follow-up was 8.4 years. High serum uric acid levels were associated with risk of myocardial infarction and stroke; age- and sex-adjusted hazard ratios (95% CIs) for highest versus lowest quintile of uric acid were 1.68 (1.24 to 2.27) for cardiovascular disease (515 cases), 1.87 (1.12 to 3.13) for myocardial infarction (194 cases), 1.57 (1.11 to 2.22) for stroke (381 cases), 1.77 (1.10 to 2.83) for ischemic stroke (205 cases), and 1.68 (0.68 to 4.15) for hemorrhagic stroke (46 cases). Adjustment for other vascular risk factors only slightly attenuated these associations. Associations were stronger in persons without hypertension than in those with hypertension. Conclusions--Uric acid is a strong risk factor for myocardial infarction and stroke.
Revised on February 9, 2006
Accepted on March 8, 2006
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke. The Rotterdam Study
Michiel J. Bos MD, MSc;
55 years of age, free from stroke and coronary heart disease, and had blood taken. Follow-up for incident stroke and myocardial infarction was complete until January 1, 2002. Data were analyzed with Cox proportional hazards models with adjustment for relevant confounders.
This article has been cited by other articles:
![]() |
A. Ascherio, P. A. LeWitt, K. Xu, S. Eberly, A. Watts, W. R. Matson, C. Marras, K. Kieburtz, A. Rudolph, M. B. Bogdanov, et al. Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease Arch Neurol, October 12, 2009; (2009) 2009.247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Vernooij, M. D. M. Haag, A. van der Lugt, A. Hofman, G. P. Krestin, B. H. Stricker, and M. M. B. Breteler Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study Arch Neurol, June 1, 2009; 66(6): 714 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Edwards Febuxostat: a new treatment for hyperuricaemia in gout Rheumatology, May 1, 2009; 48(suppl_2): ii15 - ii19. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. NEOGI, R. C. ELLISON, S. HUNT, R. TERKELTAUB, D. T. FELSON, and Y. ZHANG Serum Uric Acid Is Associated with Carotid Plaques: The National Heart, Lung, and Blood Institute Family Heart Study J Rheumatol, February 1, 2009; 36(2): 378 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Euser, A. Hofman, R. G. J. Westendorp, and M. M. B. Breteler Serum uric acid and cognitive function and dementia Brain, February 1, 2009; 132(2): 377 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pacifico, V. Cantisani, C. Anania, E. Bonaiuto, F. Martino, R. Pascone, and C. Chiesa Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children Eur. J. Endocrinol., January 1, 2009; 160(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Feig, D.-H. Kang, and R. J. Johnson Uric Acid and Cardiovascular Risk N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821. [Full Text] [PDF] |
||||
![]() |
M. T. Le, M. Shafiu, W. Mu, and R. J. Johnson SLC2A9--a fructose transporter identified as a novel uric acid transporter Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2746 - 2749. [Full Text] [PDF] |
||||
![]() |
M. A. Schwarzschild, S. R. Schwid, K. Marek, A. Watts, A. E. Lang, D. Oakes, I. Shoulson, A. Ascherio, and and the Parkinson Study Group PRECEPT Investigator Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease Arch Neurol, June 1, 2008; 65(6): 716 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dehghan, M. van Hoek, E. J.G. Sijbrands, A. Hofman, and J. C.M. Witteman High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes Diabetes Care, February 1, 2008; 31(2): 361 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strasak, E. Ruttmann, L. Brant, C. Kelleher, J. Klenk, H. Concin, G. Diem, K. Pfeiffer, H. Ulmer, and and the VHM&PP Study Group Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men Clin. Chem., February 1, 2008; 54(2): 273 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-L. Chien, M.-F. Chen, H.-C. Hsu, W.-T. Chang, T.-C. Su, Y.-T. Lee, and F. B. Hu Plasma Uric Acid and the Risk of Type 2 Diabetes in a Chinese Community Clin. Chem., February 1, 2008; 54(2): 310 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Kutzing and B. L. Firestein Altered Uric Acid Levels and Disease States J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Bos, M. J. E. van Rijn, J. C. M. Witteman, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler Incidence and Prognosis of Transient Neurological Attacks JAMA, December 26, 2007; 298(24): 2877 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Bos, P. J. Koudstaal, A. Hofman, and M. M.B. Breteler Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke: The Rotterdam Study Stroke, December 1, 2007; 38(12): 3127 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Vernooij, M. A. Ikram, H. L. Tanghe, A. J.P.E. Vincent, A. Hofman, G. P. Krestin, W. J. Niessen, M. M.B. Breteler, and A. van der Lugt Incidental Findings on Brain MRI in the General Population N. Engl. J. Med., November 1, 2007; 357(18): 1821 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, L. Qi, N. Qiao, H. K. Choi, G. Curhan, K. L. Tucker, and A. Ascherio Intake of Added Sugar and Sugar-Sweetened Drink and Serum Uric Acid Concentration in US Men and Women Hypertension, August 1, 2007; 50(2): 306 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cirillo, W. Sato, S. Reungjui, M. Heinig, M. Gersch, Y. Sautin, T. Nakagawa, and R. J. Johnson Uric Acid, the Metabolic Syndrome, and Renal Disease J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S165 - S168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qiu, B. Winblad, and L. Fratiglioni Heart Failure, Dementia, and Diuretics: Is Uric Acid Involved?--Reply Arch Intern Med, November 13, 2006; 166(20): 2287 - 2287. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |